Company Overview
DENALI THERAPEUTICS INC.
DNLIRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
0M
2025 FY
Net Income
-513M
2025 FY
Shares Outstanding
173M
2025 FY
EPS
-2.97USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1714899
Exchange
Nasdaq
Location
US